🇺🇸 FDA
Patent

US 9683985

Methods for assessing and identifying or evolving conditionally active therapeutic proteins

granted A61PA61P35/00

Quick answer

US patent 9683985 (Methods for assessing and identifying or evolving conditionally active therapeutic proteins) held by HALOZYME, INC. expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P35/00